Scarica l'app Stockscreener
1.03
6.19%
0.06
Dopo l'orario di chiusura:
.98
-0.05
-4.85%
Precedente Chiudi:
$0.97
Aprire:
$1.04
Volume 24 ore:
96,012
Relative Volume:
0.79
Capitalizzazione di mercato:
$20.15M
Reddito:
$411.00K
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-2.3409
EPS:
-0.44
Flusso di cassa netto:
$-4.88M
1 W Prestazione:
+18.39%
1M Prestazione:
+6.50%
6M Prestazione:
-43.41%
1 anno Prestazione:
-65.89%
Intervallo 1D:
$1.0202
$1.05
Intervallo di 1 settimana:
$0.823
$1.05
Portata 52W:
$0.7941
$4.38
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Nome
Lexaria Bioscience Corp
Settore
Industria
Telefono
250-765-6424
Indirizzo
100 - 740 MCCURDY ROAD, KELOWNA
Confronta LEXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
1.03 | 18.97M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexaria Bioscience Corp Borsa (LEXX) Ultime notizie
Lexaria’s DehydraTECH Technology Poised to Transform GLP-1 Industry - TipRanks
Lexaria's DehydraTECH Technology Has the Potential to Unlock Acc - GuruFocus
Lexaria’s DehydraTECH reduces side effects in GLP-1 drugs - Investing.com
Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry - TradingView
Is Lexaria Bioscience Corp. Equity Warrant a good long term investmentHigh-yield investments - Autocar Professional
What drives Lexaria Bioscience Corp. Equity Warrant stock pricePhenomenal returns - jammulinksnews.com
What analysts say about Lexaria Bioscience Corp. Equity Warrant stockConsistent high-yield stocks - jammulinksnews.com
Lexaria Bioscience Corp. Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com
How Lexaria Bioscience Corp. Equity Warrant stock performs during market volatilityVolume Spike Monitors - Newser
Is Lexaria Bioscience Corp. a good long term investmentHigh-velocity gains - jammulinksnews.com
Lexaria Bioscience Corp. Equity Warrant Stock Analysis and ForecastTriple-digit return opportunities - Autocar Professional
What drives Lexaria Bioscience Corp. stock priceSuperior stock growth - Autocar Professional
What analysts say about Lexaria Bioscience Corp. stockFree High-Return Strategy Alerts - Autocar Professional
How high can Lexaria Bioscience Corp. stock price go in 2025Short Squeeze Radar - Newser
TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Opportunity from First-Ever Work with Tirzepatide Molecule - MSN
Lexaria Bioscience stock hits 52-week low at $1.62 - MSN
Lexaria Bioscience Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Why Lexaria Bioscience Corp. stock attracts strong analyst attentionSafer Investing With Bigger Upside - Newser
How Lexaria Bioscience Corp. stock performs during market volatilityMassive Upside Selection - Newser
What makes Lexaria Bioscience Corp. Equity Warrant stock price move sharplyFree Stock Market Forums - Newser
Why Lexaria Bioscience Corp. Equity Warrant stock attracts strong analyst attentionLow Risk Entry Points - Newser
What makes Lexaria Bioscience Corp. stock price move sharplyFree Smart Money Group - Newser
Lexaria Bioscience Corp Azioni (LEXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.91%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):